Jim Cramer says Wednesday brought multiple positive earnings surprises that prompt us to ask how is it possible that these moves can occur without warning?
Jim Cramer weighs in on Canada Goose, Wix.com, Yext, Idexx Laboratories, Yeti, Clean Harbors, Nio and more.
WESTBROOK, Maine, Feb. 1, 2019 /PRNewswire/ -- Achieves revenue growth in Q4 of 9% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic Reports 15% year-over-year increase in...
Jim Cramer says that if expectations are too high, even a great quarter cannot save you from the wave of selling.
Jim Cramer takes a look at Carvana, Bank OZK, Idexx Labs, Patterson-UTI Energy, 3D Systems, AbbVie and more.
World's largest veterinary image library powers Neural Network 4.0 advancements
New in-house diagnostic enables real-time and accurate prediction of timing for canine breeding
Jim Cramer weighs in on Starbucks, Square, Alibaba, ArcelorMittal, Dynavax Technologies, Aimmune Therapeutics, Clearway Energy and more.
We may be so worried about the state of the global economy that we're missing some great opportunities, Jim Cramer says.
WESTBROOK, Maine, Jan. 9, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc.
Conflicting data about the economy should give the Federal Reserve pause.
The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.
Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.
WESTBROOK, Maine, Nov. 1, 2018 /PRNewswire/ -- Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic Delivers EPS of $1.
Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.
Jim Cramer's big takeaways? From cars and homebuilders to chips, he sees pockets of dramatic slowing.
Jim Cramer says traders hate hearing about long-term investing because they want instant payoffs.
Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.
Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.
Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.
Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.
Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.
After the recent decline, let's see what the charts look like and if there are any signals.
U.S. Stocks are set for the strongest gains in six months as global markets rebound. TheStreet's editors give some advice for investors trying to navigate the wild ride.
The narrative is shifting which means the complacency is getting squeezed out of the market.
WESTBROOK, Maine, Sept. 24, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc.
The most recent short interest data has been released for the 07/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
